Tag: United States

  • Global Health must remain a pillar of G7 and G20 agendas

    Germany’s Health Minister, Nina Warken, has made an impassioned plea for global health to remain a central pillar of the G7 and G20 agendas, as concerns grow that the United States intends to strip back the G20’s focus to its original financial mandate when it assumes the presidency next year. Speaking to an international audience at the World Health Summit…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Pharmaceutical tariffs could hike drug costs by billions

    A recent analysis commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA) indicates that a potential 25% tariff on pharmaceutical imports into the United States could dramatically increase the cost of medications for American patients. The Ernst & Young report estimates that US drug costs could surge by nearly $51 billion annually. This could lead to a price increase…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in